You are currently viewing a new version of our website. To view the old version click .

Molecular Mechanisms and Novel Therapies for Chronic Inflammatory Skin Diseases

This special issue belongs to the section “Cell Biology and Pathology“.

Special Issue Information

Dear Colleagues,

Recent major research advantages have led to notable advancements in the knowledge of the pathogenesis of inflammatory chronic skin diseases such as psoriasis, hidradenitis suppurativa, atopic dermatitis, and chronic urticaria. This has resulted in the development of new targeted therapies (biologic drugs, biosimilars, and small molecules), which have completely transformed the management of chronic inflammatory skin diseases.

The aim of this Special Issue is to collect high-value papers reporting interesting and novel data about molecular mechanisms behind chronic inflammatory skin diseases, as well as recent findings regarding currently available and future treatments, including data about experiences from real-life settings.

Dr. Angelo Ruggiero
Prof. Dr. Gabriella Fabbrocini
Dr. Matteo Megna
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • psoriasis
  • hidradenitis suppurativa
  • atopic dermatitis
  • chronic urticaria
  • biologic therapy
  • anti IL-23
  • anti IL-17
  • IL-23
  • IL-17
  • guselkumab
  • risankizumab
  • tildrakizumab
  • bimekizumab
  • Jak inhibitors
  • real-life experience
  • real-world evidence
  • molecular mechanisms
  • cytokines

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059